High-Dose Naltrexone Treatment and Gender in Alcohol Dependence

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical neuropharmacology

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/WNF.0000000000000152PMID 27046656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.

  2014cited by this paper
• Safety, tolerability, and feasibility of high‐dose naltrexone in alcohol dependence: an open‐label study

  2011influential reference
• Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

  2010cited by this paper
• Gender differences in predictors of treatment attrition with high dose naltrexone in cocaine and alcohol dependence.

  2008influential reference
• Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.

  2008cited by this paper
• Safety of High-Dose Naltrexone Treatment: Hepatic Transaminase Profiles Among Outpatients

  2006influential reference
• Alcohol craving in outpatients with alcohol dependence: rate and clinical correlates.

  2006cited by this paper
• Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials.

  2005cited by this paper
• Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial

  2005cited by this paper
• Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

  2004cited by this paper
• Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature

  2004cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

  2003cited by this paper
• Dose-Ranging Kinetics and Behavioral Pharmacology of Naltrexone and Acamprosate, Both Alone and Combined, in Alcohol-Dependent Subjects

  2003cited by this paper
• An open naltrexone treatment study in pathological gambling disorder

  2001cited by this paper
• A preliminary report on possible naltrexone and nonsteroidal analgesic interactions.

  2001cited by this paper
• Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects.

  2000cited by this paper
• Naltrexone Alters Subjective and Psychomotor Responses to Alcohol in Heavy Drinking Subjects

  2000cited by this paper
• Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.

  2000cited by this paper
• The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies.

  1996cited by this paper
• Lack of Hepatotoxicity with Naltrexone Treatment

  1994cited by this paper
• Timeline Follow-Back A Technique for Assessing Self-Reported Alcohol Consumption

  1992cited by this paper
• High-dose naltrexone therapy and dietary counseling for obesity.

  1987cited by this paper
• Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage.

  1986cited by this paper
• US Department of Health, Education and Welfare, National Institutes of Health: Regional Primate Research Centers. The Creation of a Program. Bethesda, Md. 1968. 67 pp., 2 tables. Obtainable at no cost.

  1972cited by this paper

• Geschlechterinformierte Psychopharmakotherapie von Alkoholabhängigkeit: Status Quo und Perspektive

  2026cites this paper
• Secondary analysis of a combined harm-reduction treatment and extended-release naltrexone randomized clinical trial for alcohol use disorder: Differences across race, ethnicity and sex assigned at birth.

  2025cites this paper
• KCa2 channel positive modulation reduces alcohol drinking in female C57BL/6J mice.

  2025cites this paper
• Medication treatment for alcohol use disorder in special populations.

  2023cites this paper
• Consideration of sex and gender differences in addiction medication response

  2022cites this paper
• The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder

  2022cites this paper
• Sex differences in stress-related alcohol use

  2019cites this paper
• Sex differences in the pharmacology of itch therapies-a narrative review.

  2019cites this paper
• Heterogeneity of treatment dropout: PTSD, depression, and alcohol use disorder reductions in PTSD and AUD/SUD treatment noncompleters.

  2018cites this paper
• Naltrexone in the treatment of binge eating disorder in a patient with severe alcohol use disorder: a case report

  2017cites this paper
• Baclofen and naltrexone effects on alcohol self-administration: Comparison of treatment initiated during abstinence or ongoing alcohol access in baboons.

  2017cites this paper
• Studies on new pharmacological treatments for alcohol dependence - and the importance of objective markers of alcohol consumption

  2016cites this paper